These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2898188)

  • 21. Stimulated growth hormone (GH) secretion in children with delays in pubertal development before and after the onset of puberty: relationship with peripheral plasma GH-releasing hormone and somatostatin levels.
    Saggese G; Cesaretti G; Giannessi N; Bracaloni C; Cinquanta L; Cioni C
    J Clin Endocrinol Metab; 1992 Feb; 74(2):272-8. PubMed ID: 1346143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pulsatile and nocturnal growth hormone secretions in men do not require periodic declines of somatostatin.
    Dimaraki EV; Jaffe CA; Bowers CY; Marbach P; Barkan AL
    Am J Physiol Endocrinol Metab; 2003 Jul; 285(1):E163-70. PubMed ID: 12670836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels of growth hormone-releasing hormone and somatostatin in response to a mixed meal and during sleep in children.
    Rosskamp R; Becker M; Haverkamp F; Thomas B; Brühl S; Klumpp J; Liappis N
    Acta Endocrinol (Copenh); 1987 Dec; 116(4):549-54. PubMed ID: 2892332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of growth hormone (GH)-releasing hormone and somatostatin in the mediation of clonidine-induced GH release in sheep.
    Magnan E; Cataldi M; Guillaume V; Mazzocchi L; Dutour A; Razafindraibe H; Sauze N; Renard M; Oliver C
    Endocrinology; 1994 Feb; 134(2):562-7. PubMed ID: 7905408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic growth hormone (GH) hypersecretion induces reciprocal and reversible changes in mRNA levels from hypothalamic GH-releasing hormone and somatostatin neurons in the rat.
    Bertherat J; Timsit J; Bluet-Pajot MT; Mercadier JJ; Gourdji D; Kordon C; Epelbaum J
    J Clin Invest; 1993 Apr; 91(4):1783-91. PubMed ID: 8097209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diurnal beta-endorphin changes in human cerebrospinal fluid.
    Barreca T; Siani C; Franceschini R; Francaviglia N; Messina V; Perria C; Rolandi E
    Life Sci; 1986 Jun; 38(24):2263-7. PubMed ID: 2940434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of actively immunizing sheep against growth hormone-releasing hormone or somatostatin on spontaneous pulsatile and neostigmine-induced growth hormone secretion.
    Magnan E; Mazzocchi L; Cataldi M; Guillaume V; Dutour A; Dadoun F; Le Bouc Y; Sauze N; Renard M; Conte-Devolx B
    J Endocrinol; 1995 Jan; 144(1):83-90. PubMed ID: 7891028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of growth hormone secretion from porcine fetal and neonatal pituitary tissue in vitro by growth hormone-releasing hormone, somatostatin, and insulin-like growth factor.
    Torronteras R; Gracia-Navarro F; Elsaesser F
    Neuroendocrinology; 1997 Feb; 65(2):117-28. PubMed ID: 9067989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphometric and functional changes of rat pituitary somatotropes and lactotropes after central administration of somatostatin.
    Milosević V; Brkić B; Velkovski SD; Sekulić M; Lovren M; Starcević V; Severs WB
    Pharmacology; 1998 Jul; 57(1):28-34. PubMed ID: 9670210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal, photoperiodic, and age-related changes in plasma growth hormone levels in the golden hamster.
    Laartz B; Losee-Olson S; Ge YR; Turek FW
    J Biol Rhythms; 1994; 9(2):111-23. PubMed ID: 7873771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unexpected activation of pituitary-adrenal axis in healthy young and elderly subjects during somatostatin infusion.
    Ambrosio MR; Campo M; Zatelli MC; Cella SG; Trasforini G; Margutti A; Rigamonti AE; Müller EE; degli Uberti EC
    Neuroendocrinology; 1998 Aug; 68(2):123-8. PubMed ID: 9705579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypophyseal-portal somatostatin (SRIH) and jugular venous growth hormone secretion in the conscious unrestrained ewe.
    Veldhuis JD; Fletcher TP; Gatford KL; Egan AR; Clarke IJ
    Neuroendocrinology; 2002 Feb; 75(2):83-91. PubMed ID: 11867936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone.
    Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F
    J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The neuroendocrine events during the ovine growth-promoted maturation: the developmental importance of hypophysiotrophic action of somatostatin in ewes.
    Wańkowska M; Romanowicz K; Polkowska J
    Anim Reprod Sci; 2008 Dec; 109(1-4):146-60. PubMed ID: 18243600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.
    Bertherat J; Chanson P; Dewailly D; Dupuy M; Jaquet P; Peillon F; Epelbaum J
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1577-83. PubMed ID: 7903312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of somatostatin (SRIH) and a SRIH analog, SMS 201-995, on the secretion of growth hormone and thyroid-stimulating hormone in man.
    Williams TC; Kelijman M; Crelin WC; Downs TR; Frohman LA
    J Clin Endocrinol Metab; 1988 Jan; 66(1):39-45. PubMed ID: 2891721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of rapid growth hormone (GH) pulsatility after successful removal of GH-producing pituitary tumors.
    Ho PJ; Jaffe CA; Friberg RD; Chandler WF; Barkan AL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1403-10. PubMed ID: 7911124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Half-time of endogenous growth hormone (GH) disappearance in normal man after stimulation of GH secretion by GH-releasing hormone and suppression with somatostatin.
    Faria AC; Veldhuis JD; Thorner MO; Vance ML
    J Clin Endocrinol Metab; 1989 Mar; 68(3):535-41. PubMed ID: 2563734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatostatin-secreting islet cell tumor (somatostatinoma): suppression of growth hormone (GH) release induced by GH-releasing hormone.
    Iguchi H; Kumagai S; Seo IH; Wakasugi H; Hara Y; Abe M
    J Clin Endocrinol Metab; 1988 Jul; 67(1):206-10. PubMed ID: 2897973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC; Oldfield E; Loriaux DL; Merriam GR
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.